e. coli bluescript vector (pbs Search Results


99
New England Biolabs clostridium e coli shuttle vector pwur459
Clostridium E Coli Shuttle Vector Pwur459, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pmc11906698-69-8-23?v=New+England+Biolabs
Average 99 stars, based on 1 article reviews
clostridium e coli shuttle vector pwur459 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

96
Vector Laboratories biotinylated second antibody
VTII-Bcl-2 complex formation. (A) VTII, but not VTI, contains the pentameric sequence from the Bcl-2 BH1 domain. Shown are the schematic model, sequence alignment, and protein identities and similarities of human Bcl-2, VTI and VTII. The dotted line indicates the region of splicing variants. (B,C). VTII, but not VTI, interacts with Bcl-2. Expression of Bcl-2 in V (-) and B10 (+) cells was detected with immunoblotting (IB). B10 (B) and/or V (B,C) cell extracts were separated by SDS-PAGE, and far-western blotting (FW) was performed with <t>biotinylated</t> peptides (NWGRL and NWGRI in B) or VTs (VTI and VTII in C). Interacted protein was detected with avidin-HRP and ECL. Bars on the left show positions of protein markers 46, 30, 20, and 14 kDa, from top to bottom. (D) VTII interacts with Bcl-2 through the NWGRI sequence. Far-western blotting analysis was performed with biotinylated VTII and B10 cell extracts in the presence of NWGRI (0, 1, 5, and 10 nm). (E) Coimmunoprecipitation analysis. V (-) or B10 (+) cells were treated with VTII, and then immunoprecipitates with antibodies for Bcl-2 (Bcl-2 IPs) or VTII (VTII IPs) were separated on SDS-PAGE, and immunoblotting analysis with VTII antibody was performed (VTII WB).
Biotinylated Second Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pmc00316775-195-12-23?v=Vector+Laboratories
Average 96 stars, based on 1 article reviews
biotinylated second antibody - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

99
New England Biolabs e coli bl21 de3 cells
VTII-Bcl-2 complex formation. (A) VTII, but not VTI, contains the pentameric sequence from the Bcl-2 BH1 domain. Shown are the schematic model, sequence alignment, and protein identities and similarities of human Bcl-2, VTI and VTII. The dotted line indicates the region of splicing variants. (B,C). VTII, but not VTI, interacts with Bcl-2. Expression of Bcl-2 in V (-) and B10 (+) cells was detected with immunoblotting (IB). B10 (B) and/or V (B,C) cell extracts were separated by SDS-PAGE, and far-western blotting (FW) was performed with <t>biotinylated</t> peptides (NWGRL and NWGRI in B) or VTs (VTI and VTII in C). Interacted protein was detected with avidin-HRP and ECL. Bars on the left show positions of protein markers 46, 30, 20, and 14 kDa, from top to bottom. (D) VTII interacts with Bcl-2 through the NWGRI sequence. Far-western blotting analysis was performed with biotinylated VTII and B10 cell extracts in the presence of NWGRI (0, 1, 5, and 10 nm). (E) Coimmunoprecipitation analysis. V (-) or B10 (+) cells were treated with VTII, and then immunoprecipitates with antibodies for Bcl-2 (Bcl-2 IPs) or VTII (VTII IPs) were separated on SDS-PAGE, and immunoblotting analysis with VTII antibody was performed (VTII WB).
E Coli Bl21 De3 Cells, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pm31678614-225-6-17?v=New+England+Biolabs
Average 99 stars, based on 1 article reviews
e coli bl21 de3 cells - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

93
Addgene inc gpf rnase h1 d210n gfp drh vector
VTII-Bcl-2 complex formation. (A) VTII, but not VTI, contains the pentameric sequence from the Bcl-2 BH1 domain. Shown are the schematic model, sequence alignment, and protein identities and similarities of human Bcl-2, VTI and VTII. The dotted line indicates the region of splicing variants. (B,C). VTII, but not VTI, interacts with Bcl-2. Expression of Bcl-2 in V (-) and B10 (+) cells was detected with immunoblotting (IB). B10 (B) and/or V (B,C) cell extracts were separated by SDS-PAGE, and far-western blotting (FW) was performed with <t>biotinylated</t> peptides (NWGRL and NWGRI in B) or VTs (VTI and VTII in C). Interacted protein was detected with avidin-HRP and ECL. Bars on the left show positions of protein markers 46, 30, 20, and 14 kDa, from top to bottom. (D) VTII interacts with Bcl-2 through the NWGRI sequence. Far-western blotting analysis was performed with biotinylated VTII and B10 cell extracts in the presence of NWGRI (0, 1, 5, and 10 nm). (E) Coimmunoprecipitation analysis. V (-) or B10 (+) cells were treated with VTII, and then immunoprecipitates with antibodies for Bcl-2 (Bcl-2 IPs) or VTII (VTII IPs) were separated on SDS-PAGE, and immunoblotting analysis with VTII antibody was performed (VTII WB).
Gpf Rnase H1 D210n Gfp Drh Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pm40402745-250-10-15?v=Addgene+inc
Average 93 stars, based on 1 article reviews
gpf rnase h1 d210n gfp drh vector - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Addgene inc recombinant pngasef
VTII-Bcl-2 complex formation. (A) VTII, but not VTI, contains the pentameric sequence from the Bcl-2 BH1 domain. Shown are the schematic model, sequence alignment, and protein identities and similarities of human Bcl-2, VTI and VTII. The dotted line indicates the region of splicing variants. (B,C). VTII, but not VTI, interacts with Bcl-2. Expression of Bcl-2 in V (-) and B10 (+) cells was detected with immunoblotting (IB). B10 (B) and/or V (B,C) cell extracts were separated by SDS-PAGE, and far-western blotting (FW) was performed with <t>biotinylated</t> peptides (NWGRL and NWGRI in B) or VTs (VTI and VTII in C). Interacted protein was detected with avidin-HRP and ECL. Bars on the left show positions of protein markers 46, 30, 20, and 14 kDa, from top to bottom. (D) VTII interacts with Bcl-2 through the NWGRI sequence. Far-western blotting analysis was performed with biotinylated VTII and B10 cell extracts in the presence of NWGRI (0, 1, 5, and 10 nm). (E) Coimmunoprecipitation analysis. V (-) or B10 (+) cells were treated with VTII, and then immunoprecipitates with antibodies for Bcl-2 (Bcl-2 IPs) or VTII (VTII IPs) were separated on SDS-PAGE, and immunoblotting analysis with VTII antibody was performed (VTII WB).
Recombinant Pngasef, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pmc07282979-153-6-21?v=Addgene+inc
Average 93 stars, based on 1 article reviews
recombinant pngasef - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
ATUM Bio pd434-sr e. coli expression vector
VTII-Bcl-2 complex formation. (A) VTII, but not VTI, contains the pentameric sequence from the Bcl-2 BH1 domain. Shown are the schematic model, sequence alignment, and protein identities and similarities of human Bcl-2, VTI and VTII. The dotted line indicates the region of splicing variants. (B,C). VTII, but not VTI, interacts with Bcl-2. Expression of Bcl-2 in V (-) and B10 (+) cells was detected with immunoblotting (IB). B10 (B) and/or V (B,C) cell extracts were separated by SDS-PAGE, and far-western blotting (FW) was performed with <t>biotinylated</t> peptides (NWGRL and NWGRI in B) or VTs (VTI and VTII in C). Interacted protein was detected with avidin-HRP and ECL. Bars on the left show positions of protein markers 46, 30, 20, and 14 kDa, from top to bottom. (D) VTII interacts with Bcl-2 through the NWGRI sequence. Far-western blotting analysis was performed with biotinylated VTII and B10 cell extracts in the presence of NWGRI (0, 1, 5, and 10 nm). (E) Coimmunoprecipitation analysis. V (-) or B10 (+) cells were treated with VTII, and then immunoprecipitates with antibodies for Bcl-2 (Bcl-2 IPs) or VTII (VTII IPs) were separated on SDS-PAGE, and immunoblotting analysis with VTII antibody was performed (VTII WB).
Pd434 Sr E. Coli Expression Vector, supplied by ATUM Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pmc09142965-119-10-15?v=ATUM+Bio
Average 90 stars, based on 1 article reviews
pd434-sr e. coli expression vector - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

95
SouthernBiotech rat
VTII-Bcl-2 complex formation. (A) VTII, but not VTI, contains the pentameric sequence from the Bcl-2 BH1 domain. Shown are the schematic model, sequence alignment, and protein identities and similarities of human Bcl-2, VTI and VTII. The dotted line indicates the region of splicing variants. (B,C). VTII, but not VTI, interacts with Bcl-2. Expression of Bcl-2 in V (-) and B10 (+) cells was detected with immunoblotting (IB). B10 (B) and/or V (B,C) cell extracts were separated by SDS-PAGE, and far-western blotting (FW) was performed with <t>biotinylated</t> peptides (NWGRL and NWGRI in B) or VTs (VTI and VTII in C). Interacted protein was detected with avidin-HRP and ECL. Bars on the left show positions of protein markers 46, 30, 20, and 14 kDa, from top to bottom. (D) VTII interacts with Bcl-2 through the NWGRI sequence. Far-western blotting analysis was performed with biotinylated VTII and B10 cell extracts in the presence of NWGRI (0, 1, 5, and 10 nm). (E) Coimmunoprecipitation analysis. V (-) or B10 (+) cells were treated with VTII, and then immunoprecipitates with antibodies for Bcl-2 (Bcl-2 IPs) or VTII (VTII IPs) were separated on SDS-PAGE, and immunoblotting analysis with VTII antibody was performed (VTII WB).
Rat, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pmc06232143-316-7-14?v=SouthernBiotech
Average 95 stars, based on 1 article reviews
rat - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

93
R&D Systems anti human il 6r antibody
VTII-Bcl-2 complex formation. (A) VTII, but not VTI, contains the pentameric sequence from the Bcl-2 BH1 domain. Shown are the schematic model, sequence alignment, and protein identities and similarities of human Bcl-2, VTI and VTII. The dotted line indicates the region of splicing variants. (B,C). VTII, but not VTI, interacts with Bcl-2. Expression of Bcl-2 in V (-) and B10 (+) cells was detected with immunoblotting (IB). B10 (B) and/or V (B,C) cell extracts were separated by SDS-PAGE, and far-western blotting (FW) was performed with <t>biotinylated</t> peptides (NWGRL and NWGRI in B) or VTs (VTI and VTII in C). Interacted protein was detected with avidin-HRP and ECL. Bars on the left show positions of protein markers 46, 30, 20, and 14 kDa, from top to bottom. (D) VTII interacts with Bcl-2 through the NWGRI sequence. Far-western blotting analysis was performed with biotinylated VTII and B10 cell extracts in the presence of NWGRI (0, 1, 5, and 10 nm). (E) Coimmunoprecipitation analysis. V (-) or B10 (+) cells were treated with VTII, and then immunoprecipitates with antibodies for Bcl-2 (Bcl-2 IPs) or VTII (VTII IPs) were separated on SDS-PAGE, and immunoblotting analysis with VTII antibody was performed (VTII WB).
Anti Human Il 6r Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/us11820793-2067-14-17?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
anti human il 6r antibody - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

96
Proteintech hsod1
Figure 3. Gait kinematics and locomotion characteristics. (A–D) Average running speed and stride time measured with TreadScan analyses showed significant slowing of pace in <t>hSOD1</t> males compared to WT controls (A). This finding was absent in females (C). Stride time, defined as the time elapsed between two successive initiations of stances, showed significant increases in hSOD1 males compared to WT controls (B). This finding was absent in females (D). Data represented as mean + /-SEM for (A–D). (E) Within the male hSOD1 cohort, the ANOVA was significant for effect of time on running speed, but bacterial feeding did not have a significant effect. (F) Bacterial feeding also did not significantly effect stride time. Within the male hSOD1 group, curli-fed mice showed significant differences for maximum lateral deviation of hind feet from the axis of the body (G), inability to efficiently move body from a straight axis (H), and a smaller print area of the hind feet (I) towards later months. *p < 0.05, Repeated measures two-way ANOVA or mixed-effects model analyses (REML) with Tukey’s multiple comparisons. n = 6–8 per group.
Hsod1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pm37045868-343-11-16?v=Proteintech
Average 96 stars, based on 1 article reviews
hsod1 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

90
Corning Life Sciences petri dishes
Figure 3. Gait kinematics and locomotion characteristics. (A–D) Average running speed and stride time measured with TreadScan analyses showed significant slowing of pace in <t>hSOD1</t> males compared to WT controls (A). This finding was absent in females (C). Stride time, defined as the time elapsed between two successive initiations of stances, showed significant increases in hSOD1 males compared to WT controls (B). This finding was absent in females (D). Data represented as mean + /-SEM for (A–D). (E) Within the male hSOD1 cohort, the ANOVA was significant for effect of time on running speed, but bacterial feeding did not have a significant effect. (F) Bacterial feeding also did not significantly effect stride time. Within the male hSOD1 group, curli-fed mice showed significant differences for maximum lateral deviation of hind feet from the axis of the body (G), inability to efficiently move body from a straight axis (H), and a smaller print area of the hind feet (I) towards later months. *p < 0.05, Repeated measures two-way ANOVA or mixed-effects model analyses (REML) with Tukey’s multiple comparisons. n = 6–8 per group.
Petri Dishes, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pmc05564686-29-21-23?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
petri dishes - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation plasmids protein expression escherichia coli
Figure 3. Gait kinematics and locomotion characteristics. (A–D) Average running speed and stride time measured with TreadScan analyses showed significant slowing of pace in <t>hSOD1</t> males compared to WT controls (A). This finding was absent in females (C). Stride time, defined as the time elapsed between two successive initiations of stances, showed significant increases in hSOD1 males compared to WT controls (B). This finding was absent in females (D). Data represented as mean + /-SEM for (A–D). (E) Within the male hSOD1 cohort, the ANOVA was significant for effect of time on running speed, but bacterial feeding did not have a significant effect. (F) Bacterial feeding also did not significantly effect stride time. Within the male hSOD1 group, curli-fed mice showed significant differences for maximum lateral deviation of hind feet from the axis of the body (G), inability to efficiently move body from a straight axis (H), and a smaller print area of the hind feet (I) towards later months. *p < 0.05, Repeated measures two-way ANOVA or mixed-effects model analyses (REML) with Tukey’s multiple comparisons. n = 6–8 per group.
Plasmids Protein Expression Escherichia Coli, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/pm39633052-626-5-23?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
plasmids protein expression escherichia coli - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

96
GE Healthcare e coli 269 bl21 de3
Figure 3. Gait kinematics and locomotion characteristics. (A–D) Average running speed and stride time measured with TreadScan analyses showed significant slowing of pace in <t>hSOD1</t> males compared to WT controls (A). This finding was absent in females (C). Stride time, defined as the time elapsed between two successive initiations of stances, showed significant increases in hSOD1 males compared to WT controls (B). This finding was absent in females (D). Data represented as mean + /-SEM for (A–D). (E) Within the male hSOD1 cohort, the ANOVA was significant for effect of time on running speed, but bacterial feeding did not have a significant effect. (F) Bacterial feeding also did not significantly effect stride time. Within the male hSOD1 group, curli-fed mice showed significant differences for maximum lateral deviation of hind feet from the axis of the body (G), inability to efficiently move body from a straight axis (H), and a smaller print area of the hind feet (I) towards later months. *p < 0.05, Repeated measures two-way ANOVA or mixed-effects model analyses (REML) with Tukey’s multiple comparisons. n = 6–8 per group.
E Coli 269 Bl21 De3, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli+bluescript+vector+%28pbs/chem_rxiv__11942016-109-6-41?v=GE+Healthcare
Average 96 stars, based on 1 article reviews
e coli 269 bl21 de3 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

Image Search Results


VTII-Bcl-2 complex formation. (A) VTII, but not VTI, contains the pentameric sequence from the Bcl-2 BH1 domain. Shown are the schematic model, sequence alignment, and protein identities and similarities of human Bcl-2, VTI and VTII. The dotted line indicates the region of splicing variants. (B,C). VTII, but not VTI, interacts with Bcl-2. Expression of Bcl-2 in V (-) and B10 (+) cells was detected with immunoblotting (IB). B10 (B) and/or V (B,C) cell extracts were separated by SDS-PAGE, and far-western blotting (FW) was performed with biotinylated peptides (NWGRL and NWGRI in B) or VTs (VTI and VTII in C). Interacted protein was detected with avidin-HRP and ECL. Bars on the left show positions of protein markers 46, 30, 20, and 14 kDa, from top to bottom. (D) VTII interacts with Bcl-2 through the NWGRI sequence. Far-western blotting analysis was performed with biotinylated VTII and B10 cell extracts in the presence of NWGRI (0, 1, 5, and 10 nm). (E) Coimmunoprecipitation analysis. V (-) or B10 (+) cells were treated with VTII, and then immunoprecipitates with antibodies for Bcl-2 (Bcl-2 IPs) or VTII (VTII IPs) were separated on SDS-PAGE, and immunoblotting analysis with VTII antibody was performed (VTII WB).

Journal:

Article Title: Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between Bcl-2 and tissue failure by E. coli O157:H7

doi:

Figure Lengend Snippet: VTII-Bcl-2 complex formation. (A) VTII, but not VTI, contains the pentameric sequence from the Bcl-2 BH1 domain. Shown are the schematic model, sequence alignment, and protein identities and similarities of human Bcl-2, VTI and VTII. The dotted line indicates the region of splicing variants. (B,C). VTII, but not VTI, interacts with Bcl-2. Expression of Bcl-2 in V (-) and B10 (+) cells was detected with immunoblotting (IB). B10 (B) and/or V (B,C) cell extracts were separated by SDS-PAGE, and far-western blotting (FW) was performed with biotinylated peptides (NWGRL and NWGRI in B) or VTs (VTI and VTII in C). Interacted protein was detected with avidin-HRP and ECL. Bars on the left show positions of protein markers 46, 30, 20, and 14 kDa, from top to bottom. (D) VTII interacts with Bcl-2 through the NWGRI sequence. Far-western blotting analysis was performed with biotinylated VTII and B10 cell extracts in the presence of NWGRI (0, 1, 5, and 10 nm). (E) Coimmunoprecipitation analysis. V (-) or B10 (+) cells were treated with VTII, and then immunoprecipitates with antibodies for Bcl-2 (Bcl-2 IPs) or VTII (VTII IPs) were separated on SDS-PAGE, and immunoblotting analysis with VTII antibody was performed (VTII WB).

Article Snippet: After washing with Tween-PBS, the membranes were incubated with a 1000-fold diluted biotinylated second antibody, washed with Tween-PBS, and then incubated with avidin-HRP (Vector Laboratories, Burlingame, CA) at room temperature for 1 hour.

Techniques: Sequencing, Expressing, Western Blot, SDS Page, Far Western Blot, Avidin-Biotin Assay

Figure 3. Gait kinematics and locomotion characteristics. (A–D) Average running speed and stride time measured with TreadScan analyses showed significant slowing of pace in hSOD1 males compared to WT controls (A). This finding was absent in females (C). Stride time, defined as the time elapsed between two successive initiations of stances, showed significant increases in hSOD1 males compared to WT controls (B). This finding was absent in females (D). Data represented as mean + /-SEM for (A–D). (E) Within the male hSOD1 cohort, the ANOVA was significant for effect of time on running speed, but bacterial feeding did not have a significant effect. (F) Bacterial feeding also did not significantly effect stride time. Within the male hSOD1 group, curli-fed mice showed significant differences for maximum lateral deviation of hind feet from the axis of the body (G), inability to efficiently move body from a straight axis (H), and a smaller print area of the hind feet (I) towards later months. *p < 0.05, Repeated measures two-way ANOVA or mixed-effects model analyses (REML) with Tukey’s multiple comparisons. n = 6–8 per group.

Journal: Scientific reports

Article Title: Mutant and curli-producing E. coli enhance the disease phenotype in a hSOD1-G93A mouse model of ALS.

doi: 10.1038/s41598-023-32594-5

Figure Lengend Snippet: Figure 3. Gait kinematics and locomotion characteristics. (A–D) Average running speed and stride time measured with TreadScan analyses showed significant slowing of pace in hSOD1 males compared to WT controls (A). This finding was absent in females (C). Stride time, defined as the time elapsed between two successive initiations of stances, showed significant increases in hSOD1 males compared to WT controls (B). This finding was absent in females (D). Data represented as mean + /-SEM for (A–D). (E) Within the male hSOD1 cohort, the ANOVA was significant for effect of time on running speed, but bacterial feeding did not have a significant effect. (F) Bacterial feeding also did not significantly effect stride time. Within the male hSOD1 group, curli-fed mice showed significant differences for maximum lateral deviation of hind feet from the axis of the body (G), inability to efficiently move body from a straight axis (H), and a smaller print area of the hind feet (I) towards later months. *p < 0.05, Repeated measures two-way ANOVA or mixed-effects model analyses (REML) with Tukey’s multiple comparisons. n = 6–8 per group.

Article Snippet: Tissue sections were deparaffinized, rehydrated and probed with the following antibodies: hSOD1 (SOD1 MS785, GTX57211), ChAT (ProteinTech, 20,747-1-AP), GFAP (ABclonal, A10873), Iba1 (Abcam, ab17886), Histochemistry was performed using antigen retrieval with citric acid buffer at 95C for 30 min and Vector ABC and NovaRed substrate system according to manufacturer instructions (Vector Laboratories).

Techniques:

Figure 5. Neurodegeneration, inflammation, and demyelination in the nervous system. (A,B) Within the male WT group, mutant and curli-fed mice showed significantly decreased cholinergic (ChAT+) neurons compared to vehicle. Within the vehicle group, hSOD1 males had fewer ChAT+ neurons compared to WT controls. (C,D) Within the male hSOD1 cohort, curli-fed mice showed increased astrogliosis in brainstem compared to vehicle. Images were quantified in ImageJ utilizing percent positive signal of staining. (E,F) Within the male hSOD1 cohort, mutant and curli-fed mice showed significant demyelination in white matter of spinal cords compared to vehicle groups (encroachment of pink cytoplasmic stain eosin into areas of Luxol Fast Blue stained myelin). *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA. n = 3–5 per group.

Journal: Scientific reports

Article Title: Mutant and curli-producing E. coli enhance the disease phenotype in a hSOD1-G93A mouse model of ALS.

doi: 10.1038/s41598-023-32594-5

Figure Lengend Snippet: Figure 5. Neurodegeneration, inflammation, and demyelination in the nervous system. (A,B) Within the male WT group, mutant and curli-fed mice showed significantly decreased cholinergic (ChAT+) neurons compared to vehicle. Within the vehicle group, hSOD1 males had fewer ChAT+ neurons compared to WT controls. (C,D) Within the male hSOD1 cohort, curli-fed mice showed increased astrogliosis in brainstem compared to vehicle. Images were quantified in ImageJ utilizing percent positive signal of staining. (E,F) Within the male hSOD1 cohort, mutant and curli-fed mice showed significant demyelination in white matter of spinal cords compared to vehicle groups (encroachment of pink cytoplasmic stain eosin into areas of Luxol Fast Blue stained myelin). *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA. n = 3–5 per group.

Article Snippet: Tissue sections were deparaffinized, rehydrated and probed with the following antibodies: hSOD1 (SOD1 MS785, GTX57211), ChAT (ProteinTech, 20,747-1-AP), GFAP (ABclonal, A10873), Iba1 (Abcam, ab17886), Histochemistry was performed using antigen retrieval with citric acid buffer at 95C for 30 min and Vector ABC and NovaRed substrate system according to manufacturer instructions (Vector Laboratories).

Techniques: Mutagenesis, Staining